Dual treatment with COX-2 inhibitor and sodium arsenite leads to induction of surface Fas Ligand expression and Fas-Ligand-mediated apoptosis in human melanoma cells
- 1 May 2006
- journal article
- Published by Elsevier in Experimental Cell Research
- Vol. 312 (8) , 1401-1417
- https://doi.org/10.1016/j.yexcr.2006.01.003
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- Negative Regulation of Prolactin Receptor Stability and Signaling Mediated by SCFβ-TrCP E3 Ubiquitin LigaseMolecular and Cellular Biology, 2004
- CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplantsOncogene, 2003
- Apoptosis and melanoma chemoresistanceOncogene, 2003
- Tumor necrosis factor signalingCell Death & Differentiation, 2003
- NF-κB at the crossroads of life and deathNature Immunology, 2002
- Defective death receptor signaling as a cause of tumor immune escapeSeminars in Cancer Biology, 2002
- The involvement of NF-κB in the constitutive overexpression of cyclooxygenase-2 in cyclooxygenase-1 null cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2002
- Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitorOncogene, 2001
- Prostaglandin E2 inhibits T cell activation-induced apoptosis and Fas-mediated cellular cytotoxicity by blockade of Fas-ligand inductionEuropean Journal of Immunology, 1999
- Nude rat models for human tumor metastasis to CNSJournal of Neuro-Oncology, 1994